u 69593 has been researched along with Drug Withdrawal Symptoms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadjiconstantinou, M; McCarthy, MJ; Neff, NH; Zhang, H | 1 |
| Ho, A; Kreek, MJ; Piras, AP; Schlussman, SD; Zhou, Y | 1 |
| Holtzman, SG; White, DA | 1 |
| Ho, IK; Hoskins, B; Jaw, SP; Makimura, M | 1 |
| Ho, IK; Hoshi, K; Ma, T | 1 |
| Ho, IK; Hoshi, K; Ma, T; Oh, S | 1 |
| Chefer, VI; Hope, B; Morón, JA; Rea, W; Shippenberg, TS | 1 |
| Schoffelmeer, AN; Vanderschuren, LJ; Wardeh, G | 1 |
8 other study(ies) available for u 69593 and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Nicotine withdrawal and kappa-opioid receptors.
Topics: Adenylyl Cyclase Inhibitors; Animals; Basal Ganglia; Benzeneacetamides; Caudate Nucleus; Dynorphins; GTP-Binding Proteins; Male; Mice; Nicotine; Nucleus Accumbens; Putamen; Pyrrolidines; Receptors, Opioid, kappa; RNA, Messenger; Substance Withdrawal Syndrome | 2010 |
Acute withdrawal from chronic escalating-dose binge cocaine administration alters kappa opioid receptor stimulation of [35S] guanosine 5'-O-[gamma-thio]triphosphate acid binding in the rat ventral tegmental area.
Topics: Animals; Autoradiography; Benzeneacetamides; Cocaine; Guanosine 5'-O-(3-Thiotriphosphate); Male; Pyrrolidines; Radioligand Assay; Rats; Rats, Inbred F344; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substantia Nigra; Ventral Tegmental Area | 2010 |
Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey.
Topics: Animals; Benzeneacetamides; Conditioning, Operant; Dextrorphan; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Psychological; Levorphanol; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Pyrrolidines; Receptors, Opioid; Saimiri; Substance Withdrawal Syndrome | 2003 |
Effects of nor-binaltorphimine on butorphanol dependence.
Topics: Animals; Benzeneacetamides; Body Temperature; Body Weight; Butorphanol; Diarrhea; Down-Regulation; Drug Administration Schedule; Escape Reaction; Male; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor | 1993 |
Precipitated kappa-opioid receptor agonist withdrawal increase glutamate in rat locus coeruleus.
Topics: Analgesics; Analysis of Variance; Animals; Aspartic Acid; Benzeneacetamides; Butorphanol; Glutamic Acid; Injections, Intraventricular; Locus Coeruleus; Male; Microdialysis; Naloxone; Narcotic Antagonists; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome | 1996 |
Increased release of excitatory amino acids in rat locus coeruleus in kappa-opioid agonist dependent rats precipitated by nor-binaltorphimine.
Topics: Animals; Benzeneacetamides; Butorphanol; Drug Evaluation, Preclinical; Excitatory Amino Acids; Locus Coeruleus; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Substance-Related Disorders | 1997 |
Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine.
Topics: Analgesics; Animals; Benzeneacetamides; Cocaine; Cocaine-Related Disorders; Dopamine; Drug Interactions; Extracellular Space; Male; Microdialysis; Motor Activity; Neural Pathways; Neurons; Prefrontal Cortex; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Synaptic Transmission; Synaptosomes; Ventral Tegmental Area | 2000 |
Morphine acutely and persistently attenuates nonvesicular GABA release in rat nucleus accumbens.
Topics: Analgesics; Animals; Benzeneacetamides; Carrier Proteins; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; Male; Morphine; Morphine Dependence; N-Methylaspartate; Naloxone; Neural Inhibition; Neurons; Nucleus Accumbens; Organ Culture Techniques; Pyrrolidines; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Tritium | 2001 |